The estimates of ovarian cancer penetrance by age 70 were 39% (95% CI: 34-45%) for BRCA1 mutation carriers and 17% (95% CI: 13- 21%) for BRCA2 mutation carriers. This evidence concerns the gene BRCA1 and ovarian carcinoma.